Suzuki R - Search Results

1

Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype.

Kang Y, Zhang R, Suzuki R, Li SQ, Roife D, Truty MJ, Chatterjee D, Thomas RM, Cardwell J, Wang Y, Wang H, Katz MH, Fleming JB. Kang Y, et al. Among authors: suzuki r. Lab Invest. 2015 Feb;95(2):207-22. doi: 10.1038/labinvest.2014.143. Epub 2014 Dec 8. Lab Invest. 2015. PMID: 25485535 Free PMC article.

2

Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: systematic review and meta-analysis.

Suzuki R, Thosani N, Annangi S, Komarraju A, Irisawa A, Ohira H, Obara K, Fleming JB, Guha S, Bhutani MS. Suzuki R, et al. Dig Endosc. 2014 Jul;26(4):586-93. doi: 10.1111/den.12230. Epub 2014 Jan 22. Dig Endosc. 2014. PMID: 24450356 Review.

3

Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells.

Suzuki R, Kang Y, Li X, Roife D, Zhang R, Fleming JB. Suzuki R, et al. Anticancer Res. 2014 Sep;34(9):4685-92. Anticancer Res. 2014. PMID: 25202045 Free PMC article.

4

SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium.

Kang Y, Ling J, Suzuki R, Roife D, Chopin-Laly X, Truty MJ, Chatterjee D, Wang H, Thomas RM, Katz MH, Chiao PJ, Fleming JB. Kang Y, et al. Among authors: suzuki r. PLoS One. 2014 Sep 29;9(9):e107948. doi: 10.1371/journal.pone.0107948. eCollection 2014. PLoS One. 2014. PMID: 25264609 Free PMC article.

5

Endoscopic ultrasound-assisted direct peritoneal visualization with a small-caliber scope: A proof of concept study in a swine model.

Suzuki R, Bhutani MS, Shin D, Irisawa A, Fleming JB, Richards-Kortum R, Ohira H. Suzuki R, et al. Endosc Ultrasound. 2014 Oct;3(4):226-31. doi: 10.4103/2303-9027.144535. Endosc Ultrasound. 2014. PMID: 25485270 Free PMC article.

6

Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.

Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH, Fleming JB. Kang Y, et al. Among authors: suzuki r. Clin Cancer Res. 2016 Oct 1;22(19):4934-4946. doi: 10.1158/1078-0432.CCR-15-2780. Epub 2016 Apr 28. Clin Cancer Res. 2016. PMID: 27126993 Free PMC article.

7

Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma.

Waragai Y, Suzuki R, Takagi T, Sugimoto M, Asama H, Watanabe K, Kikuchi H, Hikichi T, Masamune A, Kang Y, Fleming JB, Ohira H. Waragai Y, et al. Among authors: suzuki r. Pancreatology. 2016 Nov-Dec;16(6):1044-1050. doi: 10.1016/j.pan.2016.09.003. Epub 2016 Sep 7. Pancreatology. 2016. PMID: 27665173

8

Preparation and evaluation of polyethyleneimine-single walled carbon nanotube conjugates as vectors for pancreatic cancer treatment.

Andreoli E , Suzuki R , Orbaek AW , Bhutani MS , Hauge RH , Adams W , Fleming JB , Barron AR . Andreoli E , et al. Among authors: suzuki r. J Mater Chem B. 2014 Aug 7;2(29):4740-4747. doi: 10.1039/c4tb00778f. Epub 2014 Jun 18. J Mater Chem B. 2014. PMID: 32262286

9

The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma.

Suzuki R, Okubo Y, Takagi T, Sugimoto M, Sato Y, Irie H, Nakamura J, Takasumi M, Kato T, Hashimoto M, Kobashi R, Hikichi T, Ohira H. Suzuki R, et al. Anticancer Res. 2022 Mar;42(3):1207-1215. doi: 10.21873/anticanres.15587. Anticancer Res. 2022. PMID: 35220210

10

Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis.

Irie H, Suzuki R, Takagi T, Sugimoto M, Konno N, Sato Y, Hikichi T, Nakamura J, Hashimoto M, Ohira H. Irie H, et al. Among authors: suzuki r. Cancer Chemother Pharmacol. 2020 Mar;85(3):517-523. doi: 10.1007/s00280-019-03983-3. Epub 2019 Nov 5. Cancer Chemother Pharmacol. 2020. PMID: 31691078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,701 results

Search Page